全球自体免疫疾病诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

预计自体免疫疾病诊断市场将从 2025 年的 67.4 亿美元成长到 2034 年的 153 亿美元，2026 年至 2034 年的复合年增长率为 9.54%。

受自体免疫疾病盛行率上升和诊断技术进步的推动，自体免疫免疫疾病诊断市场预计将显着成长。随着人们对自体免疫自体免疫疾病的认识不断提高，医疗机构越来越重视早期发现和精准诊断，以改善患者预后。酵素免疫分析法(ELISA)、多重检测和次世代定序等实验室技术的创新正在提高诊断测试的灵敏度和特异性。这些进步使临床医生能够识别多种自体免疫疾病，包括类风湿性关节炎、狼疮和多发性硬化症，有助于制定及时有效的治疗策略。

此外，个人化医疗的日益普及正在影响自体免疫疾病的诊断市场。基于个别患者特征和基因标记制定治疗方案正变得越来越可行，从而实现更有效、更有针对性的干预。人工智慧 (AI) 和机器学习在诊断过程中的应用也在不断推进，使这些技术能够分析复杂的资料集、识别模式并预测疾病进展。这种向数据驱动型诊断的转变有望提高自体免疫疾病检测的准确性并改善患者管理。

此外，就地检验的兴起正在改变自体免疫疾病诊断的模式。快速且方便的检测方式在临床实务中变得至关重要，使医疗专业人员能够迅速做出明智的决策。这一趋势在偏远地区和缺乏专业诊断设施及医疗资源的地区尤其重要。总之，在技术创新、个人化诊疗方案以及为改善复杂自体免疫疾病患者的患者照护而做出的努力的推动下，自体免疫疾病诊断市场预计将迎来强劲成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球自体免疫疾病诊断市场：依产品划分

• 市场分析、洞察与预测
• 耗材和检测试剂盒
• 装置

第五章 全球自体免疫疾病诊断市场：依检测类型划分

• 市场分析、洞察与预测
• 常规检测
• 发炎标记物
• 自体抗体和免疫学检测
• 其他的

第六章 全球自体免疫疾病诊断市场：依疾病分类

• 市场分析、洞察与预测
• 类风湿性关节炎
• 全身性红斑性狼疮
• 修格兰氏症候群
• 甲状腺炎
• 硬皮症
• 其他的

第七章 全球自体免疫疾病诊断市场：依最终用户划分

• 市场分析、洞察与预测
• 临床检查室
• 医院
• 其他的

第八章 全球自体免疫疾病诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific
  • Siemens
  • Abbott
  • Danaher
  • Bio-Rad Laboratories
  • Grifols
  • Trinity Biotech
  • Werfen
  • HYCOR Biomedical
  • EUROIMMUN AG
  • Oncimmune
  • HTG Molecular Diagnostics
  • Seramun Diagnostica GmbH
  • Exagen Inc
  • Cambridge Life Sciences Limited

The Autoimmune Disease Diagnostics Market size is expected to reach USD 15.30 Billion in 2034 from USD 6.74 Billion (2025) growing at a CAGR of 9.54% during 2026-2034.

The autoimmune disease diagnostics market is poised for significant growth, driven by the increasing prevalence of autoimmune disorders and advancements in diagnostic technologies. As awareness of autoimmune diseases rises, healthcare providers are increasingly focusing on early detection and accurate diagnosis to improve patient outcomes. Innovations in laboratory techniques, such as enzyme-linked immunosorbent assays (ELISA), multiplex assays, and next-generation sequencing, are enhancing the sensitivity and specificity of diagnostic tests. These advancements enable clinicians to identify a wide range of autoimmune conditions, including rheumatoid arthritis, lupus, and multiple sclerosis, facilitating timely and effective treatment strategies.

Moreover, the growing emphasis on personalized medicine is influencing the autoimmune disease diagnostics market. Tailoring treatment plans based on individual patient profiles and genetic markers is becoming increasingly feasible, allowing for more effective and targeted interventions. The integration of artificial intelligence and machine learning in diagnostic processes is also gaining traction, as these technologies can analyze complex data sets to identify patterns and predict disease progression. This shift towards data-driven diagnostics is expected to enhance the accuracy of autoimmune disease detection and improve patient management.

Additionally, the rise of point-of-care testing is transforming the landscape of autoimmune diagnostics. Rapid and convenient testing options are becoming essential in clinical settings, enabling healthcare providers to make informed decisions quickly. This trend is particularly relevant in remote and underserved areas, where access to specialized diagnostic facilities may be limited. In summary, the autoimmune disease diagnostics market is set for robust growth, characterized by technological innovation, personalized approaches, and a commitment to improving patient care in the face of complex autoimmune conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables & Assay Kits
• Instruments

By Test Type

• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies & Immunologic Test
• Other

By Disease

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• SjAfA¶gren's Syndrome
• Thyroiditis
• Scleroderma
• Other

By End User

• Clinical Laboratories
• Hospitals
• Other

COMPANIES PROFILED

• Thermo Fisher Scientific, Siemens, Abbott, Danaher, BioRad Laboratories, Grifols, Trinity Biotech, Werfen, HYCOR Biomedical, EUROIMMUN AG, Oncimmune, HTG Molecular Diagnostics, Seramun Diagnostica GmbH, Exagen Inc, Cambridge Life Sciences Limited

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables & Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Routine Laboratory Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inflammatory Markers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Autoantibodies & Immunologic Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY DISEASE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Disease
• 6.2. Rheumatoid Arthritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Systemic Lupus Erythematosus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. SjAfA¶gren's Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Thyroiditis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Scleroderma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Test Type
  • 8.2.3 By Disease
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Test Type
  • 8.3.3 By Disease
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Test Type
  • 8.4.3 By Disease
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Test Type
  • 8.5.3 By Disease
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Test Type
  • 8.6.3 By Disease
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific
  • 10.2.2 Siemens
  • 10.2.3 Abbott
  • 10.2.4 Danaher
  • 10.2.5 Bio-Rad Laboratories
  • 10.2.6 Grifols
  • 10.2.7 Trinity Biotech
  • 10.2.8 Werfen
  • 10.2.9 HYCOR Biomedical
  • 10.2.10 EUROIMMUN AG
  • 10.2.11 Oncimmune
  • 10.2.12 HTG Molecular Diagnostics
  • 10.2.13 Seramun Diagnostica GmbH
  • 10.2.14 Exagen Inc
  • 10.2.15 Cambridge Life Sciences Limited